348 related articles for article (PubMed ID: 23031588)
1. Chemotherapy of leishmaniasis. Part IX: synthesis and bioevaluation of aryl substituted ketene dithioacetals as antileishmanial agents.
Kumar S; Tiwari A; Suryawanshi SN; Mittal M; Vishwakarma P; Gupta S
Bioorg Med Chem Lett; 2012 Nov; 22(21):6728-30. PubMed ID: 23031588
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy of leishmaniasis part II: synthesis and bioevaluation of substituted arylketene dithioacetals as antileishmanial agents.
Pandey S; Suryawanshi SN; Gupta S; Srivastava VM
Eur J Med Chem; 2005 Aug; 40(8):751-6. PubMed ID: 15907348
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of a novel series of aryl S,N-ketene acetals as antileishmanial agents.
Suryawanshi SN; Kumar S; Tiwari A; Shivahare R; Chhonker YS; Pandey S; Shakya N; Bhatta RS; Gupta S
Bioorg Med Chem Lett; 2013 Jul; 23(13):3979-82. PubMed ID: 23673014
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy of leishmaniasis part X: synthesis and bioevaluation of novel terpenyl heterocycles.
Tiwari A; Kumar S; Suryawanshi SN; Mittal M; Vishwakarma P; Gupta S
Bioorg Med Chem Lett; 2013 Jan; 23(1):248-51. PubMed ID: 23177254
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy of leishmaniasis Part VI: synthesis and bioevaluation of some novel terpenyl S,N- and N,N-acetals.
Suryawanshi SN; Pandey S; Rashmirathi ; Bhatt BA; Gupta S
Eur J Med Chem; 2007 Apr; 42(4):511-6. PubMed ID: 17178176
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy of leishmaniasis part XIII: design and synthesis of novel heteroretinoid-bisbenzylidine ketone hybrids as antileishmanial agents.
Tiwari A; Kumar S; Shivahare R; Kant P; Gupta S; Suryawanshi SN
Bioorg Med Chem Lett; 2015 Jan; 25(2):410-3. PubMed ID: 25475205
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and biological evaluation of aryl pyrimidine derivatives as potential leishmanicidal agents.
Suryawanshi SN; Kumar S; Shivahare R; Pandey S; Tiwari A; Gupta S
Bioorg Med Chem Lett; 2013 Sep; 23(18):5235-8. PubMed ID: 23910597
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of perspicamide A and related diverse analogues: their bioevaluation as potent antileishmanial agents.
Pandey AK; Sharma R; Shivahare R; Arora A; Rastogi N; Gupta S; Chauhan PM
J Org Chem; 2013 Feb; 78(4):1534-46. PubMed ID: 23289499
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy of leishmaniasis part III: synthesis and bioevaluation of novel aryl substituted terpenyl pyrimidines as antileishmanial agents.
Chandra N; Pandey S; Ramesh ; Suryawanshi SN; Gupta S
Eur J Med Chem; 2006 Jun; 41(6):779-85. PubMed ID: 16697490
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy of leishmaniasis. Part XI: synthesis and bioevaluation of novel isoxazole containing heteroretinoid and its amide derivatives.
Suryawanshi SN; Tiwari A; Chandra N; Ramesh ; Gupta S
Bioorg Med Chem Lett; 2012 Nov; 22(21):6559-62. PubMed ID: 23031597
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antileishmanial activity of novel 2,4,6-trisubstituted pyrimidines and 1,3,5-triazines.
Sunduru N; Nishi ; Palne S; Chauhan PM; Gupta S
Eur J Med Chem; 2009 Jun; 44(6):2473-81. PubMed ID: 19217698
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy of leishmaniasis part-VIII: synthesis and bioevaluation of novel chalcones.
Suryawanshi SN; Chandra N; Kumar P; Porwal J; Gupta S
Eur J Med Chem; 2008 Nov; 43(11):2473-8. PubMed ID: 18243420
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of substituted aryloxy alkyl and aryloxy aryl alkyl imidazoles as antileishmanial agents.
Bhandari K; Srinivas N; Marrapu VK; Verma A; Srivastava S; Gupta S
Bioorg Med Chem Lett; 2010 Jan; 20(1):291-3. PubMed ID: 19913413
[TBL] [Abstract][Full Text] [Related]
14. Discovery of a new antileishmanial hit in 8-nitroquinoline series.
Paloque L; Verhaeghe P; Casanova M; Castera-Ducros C; Dumètre A; Mbatchi L; Hutter S; Kraiem-M'rabet M; Laget M; Remusat V; Rault S; Rathelot P; Azas N; Vanelle P
Eur J Med Chem; 2012 Aug; 54():75-86. PubMed ID: 22608675
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of new furanyl and thiophenyl azoles as antileishmanial agents.
Marrapu VK; Mittal M; Shivahare R; Gupta S; Bhandari K
Eur J Med Chem; 2011 May; 46(5):1694-700. PubMed ID: 21385661
[TBL] [Abstract][Full Text] [Related]
16. Antileishmanial activity of benzocycloalkyl azole oximino ethers: the conformationally constraint analogues of oxiconazole.
Verma A; Srivastava S; Sane SA; Marrapu VK; Srinivas N; Yadav M; Bhandari K; Gupta S
Acta Trop; 2011 Feb; 117(2):157-60. PubMed ID: 21078278
[TBL] [Abstract][Full Text] [Related]
17. Aryloxy cyclohexyl imidazoles: a novel class of antileishmanial agents.
Srinivas N; Palne S; Nishi ; Gupta S; Bhandari K
Bioorg Med Chem Lett; 2009 Jan; 19(2):324-7. PubMed ID: 19091566
[TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of novel tetrahydronaphthyl azoles and related cyclohexyl azoles as antileishmanial agents.
Marrapu VK; Srinivas N; Mittal M; Shakya N; Gupta S; Bhandari K
Bioorg Med Chem Lett; 2011 Mar; 21(5):1407-10. PubMed ID: 21295472
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and antileishmanial activity of piperoyl-amino acid conjugates.
Singh IP; Jain SK; Kaur A; Singh S; Kumar R; Garg P; Sharma SS; Arora SK
Eur J Med Chem; 2010 Aug; 45(8):3439-45. PubMed ID: 20546981
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of 16-mercaptohexadecylphosphocholine, a miltefosine analog with leishmanicidal activity.
Hornillos V; Saugar JM; de la Torre BG; Andreu D; Rivas L; Acuña AU; Amat-Guerri F
Bioorg Med Chem Lett; 2006 Oct; 16(19):5190-3. PubMed ID: 16870434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
